期刊文献+
共找到6篇文章
< 1 >
每页显示 20 50 100
黄芪—莪术—重楼配伍对结肠癌原位移植瘤模型裸鼠肿瘤及癌旁组织中侵袭性伪足相关蛋白表达的影响 被引量:6
1
作者 关汉卿 刘甜甜 +1 位作者 梁研 唐德才 《中医杂志》 CSCD 北大核心 2021年第16期1427-1433,共7页
目的探讨黄芪-莪术-重楼配伍抗结肠癌转移的可能作用机制。方法38只裸鼠采用随机数字表法分为空白组8只及模型组、5-氟尿嘧啶(5-Fu)组和黄芪-莪术-重楼组各10只。除空白组外,其余各组裸鼠采用人结肠癌HCT116细胞原位移植法构建结肠癌原... 目的探讨黄芪-莪术-重楼配伍抗结肠癌转移的可能作用机制。方法38只裸鼠采用随机数字表法分为空白组8只及模型组、5-氟尿嘧啶(5-Fu)组和黄芪-莪术-重楼组各10只。除空白组外,其余各组裸鼠采用人结肠癌HCT116细胞原位移植法构建结肠癌原位移植瘤模型。造模24h后,5-Fu组给予注射用5-Fu 25mg/(kg·d)腹腔注射,隔日1次;黄芪-莪术-重楼组给予5.85g/(kg·d)黄芪-莪术-重楼药液灌胃,每日1次;空白组、模型组分别以10ml/(kg·d)生理盐水灌胃,每日1次。连续给药21天后计算瘤重及抑瘤率;检测各组裸鼠肿瘤及癌旁组织中酪氨酸激酶底物5(Tks5)、皮层肌动蛋白(Cortactin)、磷酸化皮层肌动蛋白(p-Cortactin)、细胞分裂周期蛋白(Cdc42)、衔接蛋白1(Nck1)、丝状肌动蛋白(F-actin)及膜型基质金属蛋白酶1(MT1-MMP)蛋白表达。结果5-Fu组、黄芪-莪术-重楼组的抑瘤率分别为58.32%、45.77%。与模型组比较,黄芪-莪术-重楼组、5-Fu组平均瘤重均降低(P<0.01);5-Fu组与黄芪-莪术-重楼组平均瘤重比较差异无统计学意义(P>0.05)。与空白组比较,模型组、黄芪-莪术-重楼组及5-Fu组肿瘤组织及癌旁组织中侵袭性伪足前体核心蛋白Tks5、p-Cortactin,侵袭性伪足成熟相关蛋白Cdc42、Nck1、F-actin、MT1-MMP蛋白表达均升高(P<0.05或P<0.01)。与模型组比较,黄芪-莪术-重楼组及5-Fu组肿瘤组织及癌旁组织中侵袭性伪足前体核心蛋白Tks5、p-Cortactin,侵袭性伪足成熟相关蛋白Cdc42、Nck1、F-actin、MT1-MMP蛋白表达均降低(P<0.01)。结论黄芪-莪术-重楼配伍可通过抑制肿瘤侵袭性伪足的形成及成熟,从而抑制结肠癌的生长与转移。 展开更多
关键词 结肠癌 黄芪 莪术 重楼 肿瘤转移 侵袭性伪足 酪氨酸激酶底物5 皮层肌动蛋白
原文传递
国医大师潘敏求治疗结直肠癌的用药规律分析 被引量:3
2
作者 李显晶 宋程 +1 位作者 王淳 唐蔚 《湖南中医药大学学报》 CAS 2022年第12期1966-1972,共7页
目的探讨国医大师潘敏求治疗结直肠癌的用药规律,为临床用药提供参考。方法收集整理潘教授治疗结直肠癌的医案,将处方录入Excel 2010建立数据库,采用古今医案云平台(V2.3.5)进行单味中药的频次分析、中药属性频次分析、药物归经频次统... 目的探讨国医大师潘敏求治疗结直肠癌的用药规律,为临床用药提供参考。方法收集整理潘教授治疗结直肠癌的医案,将处方录入Excel 2010建立数据库,采用古今医案云平台(V2.3.5)进行单味中药的频次分析、中药属性频次分析、药物归经频次统计、关联规则和聚类分析,使用Excel进行药物功效频次统计。结果纳入的300首方剂中,共使用中药138味,累计使用频次5620次,共获得甘草、白术、黄芪、茯苓、白花蛇舌草、女贞子、菟丝子、人参、枸杞子、莪术等15味核心药物,药味多甘、苦、辛,主要归脾、肝、肺经。关联规则分析获得黄芪-白术、黄芪-茯苓、白术-茯苓等50组核心药对。聚类分析获得C1(莪术、重楼)、C2(茯苓、甘草、白术、黄芪、白花蛇舌草)等3个聚类方。结论国医大师潘敏求治疗结直肠癌多从瘀、毒、虚入手,采用健脾益气、清热解毒化瘀治法,擅长攻补兼施,取得较好临床疗效。 展开更多
关键词 结直肠癌 健脾益气 清热解毒 化瘀 攻补兼施 人参 白花蛇舌草 莪术 潘敏求
下载PDF
Nrf2基因敲除对莪术神经发育毒性的影响研究
3
作者 于春磊 李成冲 +2 位作者 刘吉成 董妙先 牛英才 《中华中医药学刊》 CAS 北大核心 2020年第8期110-113,共4页
目的观察莪术对正常和血瘀证孕小鼠子代的神经发育毒性是否具有选择性及可能的生物学机制。方法采用冰水浸入法制备寒凝血瘀证小鼠模型。C57BL/6野生小鼠和Nrf2基因敲除(Nrf2-KO)小鼠分为对照组和莪术暴露组,孕小鼠从妊娠第5~18天灌胃... 目的观察莪术对正常和血瘀证孕小鼠子代的神经发育毒性是否具有选择性及可能的生物学机制。方法采用冰水浸入法制备寒凝血瘀证小鼠模型。C57BL/6野生小鼠和Nrf2基因敲除(Nrf2-KO)小鼠分为对照组和莪术暴露组,孕小鼠从妊娠第5~18天灌胃给予莪术水煎液。检测子代小鼠负趋地性达标日龄,分光光度法检测子代小鼠脑组织LPO含量和SOD活性,实时定量PCR检测子代小鼠脑组织SOD1和HO-1 mRNA表达,蛋白质印迹法检测子代小鼠脑组织HO-1蛋白表达。结果与正常对照组比较,正常小鼠灌胃莪术(10.0 g/kg)导致子代负趋地性达标日龄显著延长和脑组织LPO显著增加(均P<0.05),而血瘀证小鼠无显著差异(均P>0.05)。与正常对照组比较,血瘀证组小鼠HO-1表达,SOD活性和HO-1 mRNA表达显著增加(均P<0.05)。Nrf2基因敲除增加了血瘀证孕鼠子代断崖回避的达标日龄和脑组织氧化应激。结论莪术对正常小鼠子代的毒性效较血瘀证小鼠子代明显,Nrf2分子参与莪术神经发育毒性的有故无殒现象。 展开更多
关键词 莪术 有故无殒 血瘀证 Nrf2敲除小鼠
下载PDF
Extracts from Huangqi(Radix Astragali Mongoliciplus) and Ezhu(Rhizoma Curcumae Phaeocaulis) inhibit Lewis lung carcinoma cell growth in a xenograft mouse model by impairing mitogen-activated protein kinase signaling, vascular endothelial growth factor prod 被引量:10
4
作者 Xu Chengyong Wang Yuguo +2 位作者 Feng Jian Xu Ran Dou Yongqi 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2019年第4期559-565,共7页
OBJECTIVE: To study the anti-tumor effects of the extracts from Huangqi(Radix Astragali Mongolici)and Ezhu(Rhizoma Curcumae Phaeocaulis) on the growth of Lewis lung carcinoma(LLC) in a xenograft mouse model and to inv... OBJECTIVE: To study the anti-tumor effects of the extracts from Huangqi(Radix Astragali Mongolici)and Ezhu(Rhizoma Curcumae Phaeocaulis) on the growth of Lewis lung carcinoma(LLC) in a xenograft mouse model and to investigate the possible underlying mechanism.METHODS: LLC tumor-bearing C57 BL/6 mice were treated with normal saline, cisplatin(2 mg/kg intraperitoneally every other day), or Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis)(1∶1, 2∶1, or 3∶1 ratio;5, 8, or 11 g/kg crude drug intragastrically every day) for 15 d.Body weights and tumor volumes were measured every other day. Tumors were excised on day 15 and analyzed. Tumor microvessel density(MVD)was assessed by immunohistochemical staining of CD34;and expression of vascular endothelial cell growth factor(VEGF), the mitogen-activated protein kinases p38 mitogen-activated protein kinase(MAPK), extracellular signal-regulated kinases 1 and 2(ERK1/2), and Jun N-terminal kinase(JNK)and their phosphorylated forms were assessed by Western blotting.RESULTS: Treatment with cisplatin caused a significant loss of body weight compared with controls,whereas Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) extract combinations had no effect. Extracts from Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) significantly decreased tumor weight and tumor MVD compared with controls,and at the 3∶1 treatment group had similar efficacy to cisplatin in reducing MVD. Tumors from Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) treatments also showed decreased p38 MAPK, p-p38 MAPK, ERK1/2, p-ERK1/2,JNK, and p-JNK expression compared with the control group(all P < 0.01). VEGF protein expression was significantly reduced in the 2∶1 and 3∶1 treatment groups compared with the control group(P < 0.01).CONCLUSION: Extracts from Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) hindered LLC growth in the xenograft mouse model, possibly via inhibition of 展开更多
关键词 Carcinoma Lewis lung Vascular endothelial cell growth factors EXTRACELLULAR SIGNAL-REGULATED MAP KINASES Angiogenesis Huangqi(Radix Astragali Mongolici) ezhu(rhizoma curcumae Phaeocaulis)
原文传递
Effect of optimal combination of Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) on proliferation and apoptosis of A549 lung cancer cells 被引量:4
5
作者 Xu Chengyong Wang Yuguo +3 位作者 Feng Jian Qin Li Xu Ran Dou Yongqi 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2018年第3期351-358,共8页
OBJECTIVE: To investigate the effect of optimal combination(E) of Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) on proliferation and apoptosis of A549 lung cancer cells and the possible mec... OBJECTIVE: To investigate the effect of optimal combination(E) of Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) on proliferation and apoptosis of A549 lung cancer cells and the possible mechanism underpinning the action.METHODS: A uniform design method was used to optimize the E of Huangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) in A549 lung cancer cells. MTS assay was applied to analyze the effect of the component formula ofHuangqi(Radix Astragali Mongolici) and Ezhu(Rhizoma Curcumae Phaeocaulis) on A549 cells viability in various uniform design groups. A549 cells with exponential growth in routine culture were exposed to Co Cl_2(200 μmol/L) to mimic hypoxic conditions. Group 0 was treated with RPMI-1640, the group Co Cl_2 was treated with Co Cl_2(200 μmol/L),the group DDP + Co Cl_2 was treated with 4 mg/L Cisplatin injection(DDP) + Co Cl_2(200 μmol/L), and the drug group was treated with various dose of E(0.5 E, 1 E, 2 E) + Co Cl_2(200 μmol/L). All groups were cultured for 24 h. Cell apoptosis was measured by Annexin V-FITC/propidium iodide double staining and flow cytometry. Western blot assay and quantitative real-time polymerase chain reaction(q RT-PCR) were employed to detect the protein and m RNA expression of B-celllymphoma-2(Bcl-2),Bcl-2-associated X protein(Bax) and cysteinyl aspartate specific proteinase-3(caspase-3).RESULTS: The E obtained by the uniform design was comprise of 200 mg/L Astragalus polysaccharide(X1) and 32 mg/L Curcumin(X3). Group DDP+Co Cl_2, group 1 E + Co Cl_2 and group 2 E + Co Cl_2 promoted the apoptosis of A549 cells(P < 0.05). Group1 E + Co Cl_2 and group 2 E + Co Cl_2 had no statistically significant differences compared with the group DDP + Co Cl_2(P > 0.05). Compared with group 0, various doses of E + Co Cl_2 could up-regulate the expression of Bax and caspase-3 and down-regulate the expression of Bcl-2 at protein and m RNA levels(P < 0.05).CONCLUSION: Astragalus polysaccharide and Curcumin was the optimal combination 展开更多
关键词 LUNG NEOPLASMS A549 cells Apoptosis Astragalan Huangqi (Radix Astragali Mongolici) ezhu (rhizoma curcumae Phaeocaulis) CURCUMIN HYPOXIA
原文传递
莪术、白术挥发油提取及包合工艺考察 被引量:7
6
作者 吴桐 张相林 +3 位作者 宋威江 李蕊 耿怡玮 姚树坤 《中医药导报》 2015年第5期26-28,共3页
目的:研究莪术、白术挥发油提取及包合的最佳工艺条件。方法:采用单因素考察法,以挥发油得量为指标,考察药材粉碎度、加水量、浸泡时间、提取时间对挥发油的提取影响,优选提取工艺;采用正交试验法,以挥发油利用率、包合物含油率、包合... 目的:研究莪术、白术挥发油提取及包合的最佳工艺条件。方法:采用单因素考察法,以挥发油得量为指标,考察药材粉碎度、加水量、浸泡时间、提取时间对挥发油的提取影响,优选提取工艺;采用正交试验法,以挥发油利用率、包合物含油率、包合物收率综合评分为指标,考察挥发油与β-环糊精的用量比、包合时间、包合温度对挥发油包合的影响,优选出最佳工艺。结果:最佳提取工艺为过20目筛粗粉,加6倍量水,不浸泡,提取6 h;最佳包合工艺为挥发油与β-环糊精的用量比1:6,包合120 min,包合温度为50℃。结论:该提取方法可较完全地提取莪术、白术挥发油,经β-环糊精包合后,性质稳定,包合工艺简单可行。 展开更多
关键词 莪术 白术 挥发油 提取工艺 包合
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部